Quesenberry Peter J, Colvin Gerald A, Lambert Jean-Francois, Frimberger Angela E, Dooner Mark S, Mcauliffe Christina I, Miller Caroline, Becker Pamela, Badiavas Evangelis, Falanga Vincent J, Elfenbein Gerald, Lum Lawrence G
Department of Research, Roger Williams Medical Center, 825 Chalkstone Avenue, Providence, RI 02908, USA.
Trans Am Clin Climatol Assoc. 2002;113:182-206; discussion 206-7.
Recent studies have indicated that bone marrow stem cells are capable of generating muscle, cardiac, hepatic, renal, and bone cells. Purified hematopoietic stem cells have generated cardiac and hepatic cells and reversed disease manifestations in these tissues. Hematopoietic stem cells also alter phenotype with cell cycle transit or circadian phase. During a cytokine stimulated cell cycle transit, reversible alterations of differentiation and engraftment occur. Primitive hematopoietic stem cells express a wide variety of adhesion and cytokine receptors and respond quickly with migration and podia extensions on exposure to cytokines. These data suggest an "Open Chromatin" model of stem cell regulation in which there is a fluctuating continuum in the stem cell/progenitor cell compartments, rather than a hierarchical relationship. These observations, along with progress in using low dose treatments and tolerization approaches, suggest many new therapeutic strategies involving stem cells and the creation of a new medical specialty; stemology.
最近的研究表明,骨髓干细胞能够生成肌肉、心脏、肝脏、肾脏和骨细胞。纯化的造血干细胞已生成心脏和肝细胞,并逆转了这些组织中的疾病表现。造血干细胞也会随着细胞周期进程或昼夜节律阶段而改变表型。在细胞因子刺激的细胞周期进程中,分化和植入会发生可逆性改变。原始造血干细胞表达多种黏附分子和细胞因子受体,在接触细胞因子时会迅速通过迁移和伪足延伸做出反应。这些数据提示了一种干细胞调控的“开放染色质”模型,其中干细胞/祖细胞区室存在波动的连续统一体,而非层级关系。这些观察结果,连同在使用低剂量治疗和免疫耐受方法方面取得的进展,提示了许多涉及干细胞的新治疗策略以及一门新医学专业的创立;干细胞学。